{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:47:51Z","timestamp":1783990071885,"version":"3.55.0"},"reference-count":106,"publisher":"Georg Thieme Verlag KG","issue":"02","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Facial Plast Surg"],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Androgenetic alopecia is a common type of hair loss, which is generally influenced by genetic factors and systemic androgens resulting in follicular miniaturization.1 It can cause cosmetic problems leading to psychological distress among affected men and women. Effective standard medical treatments available are topical minoxidil 2 to 5%, oral finasteride, oral dutasteride, and hair transplantation.1 However, some patients do not achieve favorable results with standard treatments. For these reasons, other novel treatments have been developed, including new medications, regenerative medicines (autologous platelet-rich plasma, adipose-derived stem cells, micrograft generation, and exosome), and low-level laser therapy<\/jats:p>","DOI":"10.1055\/a-2196-4713","type":"journal-article","created":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T23:14:45Z","timestamp":1698102885000},"page":"252-266","source":"Crossref","is-referenced-by-count":8,"title":["Medical Treatment for Androgenetic Alopecia"],"prefix":"10.1055","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5307-3164","authenticated-orcid":false,"given":"Ratchathorn","family":"Panchaprateep","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand"},{"name":"Absolute Hair Clinic, Bangkok Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2023,12,4]]},"reference":[{"issue":"03","key":"ref1","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1067\/mjd.2002.124088","article-title":"A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men","volume":"47","author":"E ADF Olsen","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"01","key":"ref2","first-page":"5","article-title":"Androgenetic alopecia and current methods of treatment","volume":"14","author":"M Bienov\u00e1","year":"2005","journal-title":"Acta Dermatovenerol Alp Panonica Adriat"},{"issue":"05","key":"ref3","doi-asserted-by":"crossref","first-page":"e13059","DOI":"10.1111\/dth.13059","article-title":"Physiopathology and current treatments of androgenetic alopecia: going beyond androgens and anti-androgens","volume":"32","author":"T Katzer","year":"2019","journal-title":"Dermatol Ther"},{"issue":"08","key":"ref4","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s40265-023-01880-x","article-title":"Androgenetic alopecia: therapy update","volume":"83","author":"S Devjani","year":"2023","journal-title":"Drugs"},{"issue":"12","key":"ref5","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1111\/jocd.14537","article-title":"Treatment options for androgenetic alopecia: efficacy, side effects, compliance, financial considerations, and ethics","volume":"20","author":"M S Nestor","year":"2021","journal-title":"J Cosmet Dermatol"},{"issue":"02","key":"ref6","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2133.2004.05785.x","article-title":"Minoxidil: mechanisms of action on hair growth","volume":"150","author":"A G Messenger","year":"2004","journal-title":"Br J Dermatol"},{"issue":"02","key":"ref7","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/jdv.17738","article-title":"Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial","volume":"36","author":"B M Piraccini","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"07","key":"ref8","first-page":"e42768","article-title":"Comparing current therapeutic modalities of androgenic alopecia: a literature review of clinical trials","volume":"15","author":"P S Bajoria","year":"2023","journal-title":"Cureus"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14764172.2023.2222942","article-title":"Combination therapy in female pattern hair loss","volume":"25","author":"S Deoghare","year":"2023","journal-title":"J Cosmet Laser Ther"},{"issue":"01","key":"ref10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40257-022-00730-y","article-title":"What's new in therapy for male androgenetic alopecia?","volume":"24","author":"D Saceda-Corralo","year":"2023","journal-title":"Am J Clin Dermatol"},{"issue":"02","key":"ref11","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1080\/09546634.2020.1782324","article-title":"Topical finasteride for the treatment of male androgenetic alopecia and female pattern hair loss: a review of the current literature","volume":"33","author":"P Suchonwanit","year":"2022","journal-title":"J Dermatolog Treat"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40257-022-00730-y","article-title":"What's new in therapy for male androgenetic alopecia?","volume":"24","author":"D Saceda-Corralo","year":"2023","journal-title":"Am J Clin Dermatol"},{"issue":"12","key":"ref13","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1111\/jdv.15171","article-title":"A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia","volume":"32","author":"P Suchonwanit","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"03","key":"ref14","first-page":"703","article-title":"The effect of finasteride, a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness","volume":"79","author":"A L Dallob","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"issue":"04","key":"ref15","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1067\/mjd.2002.120537","article-title":"Changes in hair weight and hair count in men with androgenetic alopecia after treatment with finasteride, 1\u2009mg, daily","volume":"46","author":"V H Price","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"01","key":"ref16","first-page":"32","article-title":"Finasteride improves male pattern hair loss in a randomized study in identical twins","volume":"12","author":"D B Stough","year":"2002","journal-title":"Eur J Dermatol"},{"issue":"02","key":"ref17","doi-asserted-by":"crossref","first-page":"128","DOI":"10.4103\/0378-6323.177432","article-title":"Guidelines on the use of finasteride in androgenetic alopecia","volume":"82","author":"V Mysore","year":"2016","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"01","key":"ref18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/jocd.12983","article-title":"Excellent response to mesotherapy as adjunctive treatment in male androgenetic alopecia","volume":"19","author":"D F Melo","year":"2020","journal-title":"J Cosmet Dermatol"},{"issue":"01","key":"ref19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1346-8138.2011.01378.x","article-title":"Evaluation of efficacy and safety of finasteride 1\u2009mg in 3177 Japanese men with androgenetic alopecia","volume":"39","author":"A Sato","year":"2012","journal-title":"J Dermatol"},{"issue":"04","key":"ref20","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0022-5347(05)68270-5","article-title":"Chronic treatment with finasteride daily does not affect spermatogenesis or semen production in young men","volume":"162","author":"J W Overstreet","year":"1999","journal-title":"J Urol"},{"key":"ref21","first-page":"849","article-title":"Propecia-induced spermatogenesis failure: a report of two cases","volume":"90","author":"K EBS Liu","year":"2008","journal-title":"Fertil Steril"},{"issue":"03","key":"ref22","doi-asserted-by":"crossref","first-page":"370","DOI":"10.5021\/ad.2012.24.3.370","article-title":"Efficacy of finasteride 1.25\u2009mg on female pattern hair loss; pilot study","volume":"24","author":"W J Kim","year":"2012","journal-title":"Ann Dermatol"},{"issue":"02","key":"ref23","first-page":"e12588","article-title":"Clinical efficacy of oral administration of finasteride at a dose of 2.5\u2009mg\/day in women with female pattern hair loss","volume":"31","author":"Y Y Won","year":"2018","journal-title":"Dermatol Ther"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"951","DOI":"10.2147\/DDDT.S240615","article-title":"Finasteride and its potential for the treatment of female pattern hair loss: evidence to date","volume":"14","author":"W Iamsumang","year":"2020","journal-title":"Drug Des Devel Ther"},{"issue":"03","key":"ref25","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1001\/jamadermatol.2021.5743","article-title":"Relative efficacy of minoxidil and the 5-\u03b1 reductase inhibitors in androgenetic alopecia treatment of male patients: a network meta-analysis","volume":"158","author":"A K Gupta","year":"2022","journal-title":"JAMA Dermatol"},{"issue":"07","key":"ref26","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1080\/09546634.2022.2109567","article-title":"Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia","volume":"33","author":"A K Gupta","year":"2022","journal-title":"J Dermatolog Treat"},{"issue":"06","key":"ref27","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jaad.2006.05.007","article-title":"The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride","volume":"55","author":"E A Olsen","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1210\/jc.2006-2203","article-title":"The effect of 5-alpha-reductase on semen parameters and serum hormones in healthy men","volume":"92","author":"J KWC Amory","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"01","key":"ref29","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jaad.2008.12.026","article-title":"Treatment of postmenopausal frontal fibrosing alopecia with oral dutasteride","volume":"61","author":"S Georgala","year":"2009","journal-title":"J Am Acad Dermatol"},{"issue":"05","key":"ref30","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1468-3083.2008.02963.x","article-title":"Frontal fibrosing alopecia: treatment with oral dutasteride and topical pimecrolimus","volume":"23","author":"A Katoulis","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"05","key":"ref31","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.jaad.2020.09.093","article-title":"Effectiveness of dutasteride in a large series of patients with frontal fibrosing alopecia in real clinical practice","volume":"84","author":"C Pindado-Ortega","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"01","key":"ref32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10549-018-4996-3","article-title":"Safety of 5\u03b1-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies","volume":"174","author":"R N Rozner","year":"2019","journal-title":"Breast Cancer Res Treat"},{"issue":"01","key":"ref33","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1684\/ejd.2023.4443","article-title":"Mesotherapy with dutasteride for androgenetic alopecia: a concise review of the literature","volume":"33","author":"F J Rodr\u00edguez-Cuadrado","year":"2023","journal-title":"Eur J Dermatol"},{"issue":"07","key":"ref34","first-page":"742","article-title":"Mesotherapy with dutasteride for androgenetic alopecia: a retrospective study in real clinical practice","volume":"21","author":"D Saceda-Corralo","year":"2022","journal-title":"J Drugs Dermatol"},{"issue":"03","key":"ref35","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4103\/ijt.ijt_73_16","article-title":"Mesotherapy with dutasteride in the treatment of androgenetic alopecia","volume":"9","author":"D Saceda-Corralo","year":"2017","journal-title":"Int J Trichology"},{"issue":"01","key":"ref36","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/ijd.13838","article-title":"Female pattern hair loss: a pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone","volume":"57","author":"R D Sinclair","year":"2018","journal-title":"Int J Dermatol"},{"issue":"06","key":"ref37","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s13555-020-00448-x","article-title":"Efficacy and safety of oral minoxidil 5\u2009mg once daily in the treatment of male patients with androgenetic alopecia: an open-label and global photographic assessment","volume":"10","author":"R Panchaprateep","year":"2020","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"05","key":"ref38","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.jaad.2020.05.129","article-title":"Efficacy and safety of very-low-dose oral minoxidil 1.25\u2009mg in male androgenetic alopecia","volume":"83","author":"A K Jha","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"06","key":"ref39","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.jaad.2020.10.097","article-title":"Combination oral minoxidil and spironolactone for the treatment of androgenetic alopecia in adolescent girls","volume":"84","author":"B Olamiju","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"01","key":"ref40","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jaad.2019.08.084","article-title":"Very-low-dose oral minoxidil in male androgenetic alopecia: a study with quantitative trichoscopic documentation","volume":"82","author":"R Pirmez","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"06","key":"ref41","doi-asserted-by":"crossref","first-page":"e14234","DOI":"10.1111\/dth.14234","article-title":"Efficacy and safety of oral minoxidil in female androgenetic alopecia","volume":"33","author":"M Vastarella","year":"2020","journal-title":"Dermatol Ther"},{"issue":"03","key":"ref42","first-page":"e200","article-title":"Low-dose oral minoxidil increases hair density and thickness in androgenetic alopecia: a retrospective analysis of 60 patients","volume":"36","author":"L Yin","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"01","key":"ref43","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1177\/1203475419879887","article-title":"Oral minoxidil: a possible new therapy for androgenetic alopecia","volume":"24","author":"A Gomolin","year":"2020","journal-title":"J Cutan Med Surg"},{"issue":"01","key":"ref44","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jaad.2019.08.060","article-title":"Minoxidil 1\u2009mg oral versus minoxidil 5% topical solution for the treatment of female-pattern hair loss: a randomized clinical trial","volume":"82","author":"P M Ramos Sr","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"05","key":"ref45","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1159\/000525137","article-title":"There is a positive dose-dependent association between low-dose oral minoxidil and its efficacy for androgenetic alopecia: findings from a systematic review with meta-regression analyses","volume":"8","author":"A K Gupta","year":"2022","journal-title":"Skin Appendage Disord"},{"issue":"06","key":"ref46","doi-asserted-by":"crossref","first-page":"e14106","DOI":"10.1111\/dth.14106","article-title":"Safety of low-dose oral minoxidil treatment for hair loss. A systematic review and pooled-analysis of individual patient data","volume":"33","author":"J Jimenez-Cauhe","year":"2020","journal-title":"Dermatol Ther"},{"issue":"03","key":"ref47","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000505820","article-title":"Low-dose oral minoxidil for female pattern hair loss: a unicenter descriptive study of 148 women","volume":"6","author":"R Rodrigues-Barata","year":"2020","journal-title":"Skin Appendage Disord"},{"issue":"03","key":"ref48","doi-asserted-by":"crossref","first-page":"270","DOI":"10.23736\/S2784-8671.23.07500-X","article-title":"Could oral minoxidil be superior to its topical variant for treatment of female pattern hair loss?","volume":"158","author":"M Vastarella","year":"2023","journal-title":"Ital J Dermatol Venereol"},{"issue":"01","key":"ref49","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1111\/jdv.17623","article-title":"Sublingual minoxidil for the treatment of male and female pattern hair loss: a randomized, double-blind, placebo-controlled, phase 1B clinical trial","volume":"36","author":"L Bokhari","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"08","key":"ref50","first-page":"e43559","article-title":"The efficacy and safety of oral spironolactone in the treatment of female pattern hair loss: a systematic review and meta-analysis","volume":"15","author":"M Aleissa","year":"2023","journal-title":"Cureus"},{"issue":"01","key":"ref51","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jaad.2020.03.087","article-title":"Spironolactone for treatment of female pattern hair loss","volume":"83","author":"L J Burns","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.15979","article-title":"The efficacy of the combination of topical minoxidil and oral spironolactone compared with the combination of topical minoxidil and oral finasteride in women with androgenic alopecia, female and male hair loss patterns: a blinded randomized clinical trial","author":"A S Bazargan","year":"2023","journal-title":"J Cosmet Dermatol"},{"issue":"07","key":"ref53","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1210\/jc.2018-02548","article-title":"Female pattern hair loss and androgen excess: a report from the multidisciplinary androgen excess and PCOS committee","volume":"104","author":"E Carmina","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"ref54","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1111\/jocd.14773","article-title":"Bicalutamide and the new perspectives for female pattern hair loss treatment: what dermatologists should know","volume":"21","author":"R M Carvalho","year":"2022","journal-title":"J Cosmet Dermatol"},{"issue":"05","key":"ref55","doi-asserted-by":"crossref","first-page":"e355","DOI":"10.1016\/j.jaad.2020.04.054","article-title":"Bicalutamide: a potential new oral antiandrogenic drug for female pattern hair loss","volume":"83","author":"D Fernandez-Nieto","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"06","key":"ref56","doi-asserted-by":"crossref","first-page":"e13096","DOI":"10.1111\/dth.13096","article-title":"Oral bicalutamide for female pattern hair loss: a pilot study","volume":"32","author":"D Fernandez-Nieto","year":"2019","journal-title":"Dermatol Ther"},{"issue":"05","key":"ref57","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.jaad.2020.03.034","article-title":"Safety of oral bicalutamide in female pattern hair loss: a retrospective review of 316 patients","volume":"83","author":"F F Ismail","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"02","key":"ref58","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jaad.2021.10.048","article-title":"Bicalutamide improves minoxidil-induced hypertrichosis in female pattern hair loss: a retrospective review of 35 patients","volume":"87","author":"A Moussa","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"04","key":"ref59","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/DSS.0000000000000665","article-title":"Randomized placebo-controlled, double-blind, half-head study to assess the efficacy of platelet-rich plasma on the treatment of androgenetic alopecia","volume":"42","author":"R Alves","year":"2016","journal-title":"Dermatol Surg"},{"issue":"02","key":"ref60","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/1203475418818073","article-title":"The efficacy of platelet-rich plasma in the field of hair restoration and facial aesthetics\u2014a systematic review and meta-analysis","volume":"23","author":"A K Gupta","year":"2019","journal-title":"J Cutan Med Surg"},{"issue":"03","key":"ref61","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3390\/jpm12030342","article-title":"Effectiveness of platelet-rich plasma therapy in androgenic alopecia\u2014a meta-analysis","volume":"12","author":"S R Georgescu","year":"2022","journal-title":"J Pers Med"},{"issue":"10","key":"ref62","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1111\/jocd.14963","article-title":"Combination of platelet-rich plasma and platelet gel in treatment of resistance androgenic alopecia: a case series study","volume":"21","author":"E Lotfi","year":"2022","journal-title":"J Cosmet Dermatol"},{"issue":"09","key":"ref63","doi-asserted-by":"crossref","first-page":"943","DOI":"10.36849\/JDD.6948","article-title":"Platelet-rich plasma monotherapies for androgenetic alopecia: a network meta-analysis and meta-regression study","volume":"21","author":"A K Gupta","year":"2022","journal-title":"J Drugs Dermatol"},{"issue":"01","key":"ref64","doi-asserted-by":"crossref","first-page":"2138692","DOI":"10.1080\/09546634.2022.2138692","article-title":"Use of autologous platelet-rich plasma in androgenetic alopecia in women: a systematic review and meta-analysis","volume":"34","author":"A FQ de Oliveira","year":"2023","journal-title":"J Dermatolog Treat"},{"issue":"05","key":"ref65","first-page":"739e","article-title":"Autologous platelet-rich plasma treatment for androgenic alopecia: a systematic review and meta-analysis of clinical trials","volume":"151","author":"M Papakonstantinou","year":"2023","journal-title":"Plast Reconstr Surg"},{"issue":"09","key":"ref66","first-page":"e28801","article-title":"Patient satisfaction and clinical effects of platelet-rich plasma on pattern hair loss in male and female patients","volume":"14","author":"S P Hetz","year":"2022","journal-title":"Cureus"},{"issue":"02","key":"ref67","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4103\/ijt.ijt_65_22","article-title":"Effect of platelet-rich plasma and other key factors on hair follicle preservation","volume":"15","author":"R Thuangtong","year":"2023","journal-title":"Int J Trichology"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.15861","article-title":"Efficacy of autologous platelet-rich plasma combined with a non-cross-linked hyaluronic acid compound in the treatment of female androgenetic alopecia: a retrospective, case-series study","author":"S Wang","year":"2023","journal-title":"J Cosmet Dermatol"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1177\/12034754231191461","article-title":"Platelet-rich plasma for androgenetic alopecia: a systematic review and meta-analysis of randomized controlled trials","author":"X Zhang","year":"2023","journal-title":"J Cutan Med Surg"},{"issue":"05","key":"ref70","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1111\/jocd.15617","article-title":"An umbrella review of the use of platelet-rich plasma in the treatment of androgenetic alopecia","volume":"22","author":"C Li","year":"2023","journal-title":"J Cosmet Dermatol"},{"issue":"09","key":"ref71","first-page":"905","article-title":"A randomized control trial comparing the efficacy of platelet-rich plasma and 5% topical minoxidil for the treatment of androgenetic alopecia","volume":"22","author":"M Asim","year":"2023","journal-title":"J Drugs Dermatol"},{"issue":"01","key":"ref72","doi-asserted-by":"crossref","first-page":"2182618","DOI":"10.1080\/09546634.2023.2182618","article-title":"Efficacy of autologous platelet-rich plasma therapy versus topical Minoxidil in men with moderate androgenetic alopecia: a randomized open-label trial","volume":"34","author":"M Balasundaram","year":"2023","journal-title":"J Dermatolog Treat"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.15873","article-title":"Clinical study on the efficacy and tolerability of a topical regenerative treatment in patients with telogen effluvium and mild androgenetic alopecia","author":"S Cedirian","year":"2023","journal-title":"J Cosmet Dermatol"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.2147\/CCID.S385861","article-title":"Treatment of androgenetic alopecia: current guidance and unmet needs","volume":"16","author":"M Kaiser","year":"2023","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"06","key":"ref75","doi-asserted-by":"crossref","first-page":"e2875","DOI":"10.1097\/GOX.0000000000002875","article-title":"Effect of platelet rich plasma versus saline solution as a preservation solution for hair transplantation","volume":"8","author":"R Abdelkader","year":"2020","journal-title":"Plast Reconstr Surg Glob Open"},{"issue":"01","key":"ref76","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.mjafi.2021.04.015","article-title":"Randomized control trial to study the efficacy and safety of platelet-rich plasma as intraoperative holding solution in hair restoration surgery: a pilot study","volume":"79","author":"V Pathania","year":"2023","journal-title":"Med J Armed Forces India"},{"issue":"11","key":"ref77","first-page":"E64","article-title":"A systematic review and meta-analysis of randomized controlled trials of United States Food and Drug Administration-approved, home-use, low-level light\/laser therapy devices for pattern hair loss: device design and technology","volume":"14","author":"S Lueangarun","year":"2021","journal-title":"J Clin Aesthet Dermatol"},{"issue":"06","key":"ref78","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1080\/09546634.2019.1688755","article-title":"Meta-analysis of photobiomodulation for the treatment of androgenetic alopecia","volume":"32","author":"A K Gupta","year":"2021","journal-title":"J Dermatolog Treat"},{"issue":"06","key":"ref79","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s10103-019-02723-6","article-title":"Comparative effectiveness of low-level laser therapy for adult androgenic alopecia: a system review and meta-analysis of randomized controlled trials","volume":"34","author":"K H Liu","year":"2019","journal-title":"Lasers Med Sci"},{"issue":"06","key":"ref80","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s10103-015-1775-9","article-title":"Evaluation of wavelength-dependent hair growth effects on low-level laser therapy: an experimental animal study","volume":"30","author":"T H Kim","year":"2015","journal-title":"Lasers Med Sci"},{"issue":"04","key":"ref81","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/14764172.2017.1400174","article-title":"Use of low-level laser therapy in treatment of the androgenic alopecia, the first systematic review","volume":"20","author":"I Najem","year":"2018","journal-title":"J Cosmet Laser Ther"},{"issue":"04","key":"ref82","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/14764172.2017.1400170","article-title":"Systematic review of low-level laser therapy for adult androgenic alopecia","volume":"20","author":"S W Delaney","year":"2018","journal-title":"J Cosmet Laser Ther"},{"issue":"01","key":"ref83","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1080\/09546634.2020.1749547","article-title":"Efficacy of non-surgical treatments for androgenetic alopecia in men and women: a systematic review with network meta-analyses, and an assessment of evidence quality","volume":"33","author":"A K Gupta","year":"2022","journal-title":"J Dermatolog Treat"},{"issue":"01","key":"ref84","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jaad.2017.02.054","article-title":"The effectiveness of treatments for androgenetic alopecia: a systematic review and meta-analysis","volume":"77","author":"A Adil","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"ref85","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1111\/jdv.15081","article-title":"Efficacy of non-surgical treatments for androgenetic alopecia: a systematic review and network meta-analysis","volume":"32","author":"A K Gupta","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"58","DOI":"10.21037\/sci.2017.06.04","article-title":"Stem cells from human hair follicles: first mechanical isolation for immediate autologous clinical use in androgenetic alopecia and hair loss","volume":"4","author":"P Gentile","year":"2017","journal-title":"Stem Cell Investig"},{"key":"ref88","first-page":"e2894","article-title":"Advances in stem cell-based therapy for hair loss","volume":"8","author":"A Egger","year":"2020","journal-title":"CellR4 Repair Replace Regen Reprogram"},{"issue":"01","key":"ref89","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/jrr\/rraa106","article-title":"Extracellular vesicles released from irradiated neonatal mouse cheek tissue increased cell survival after radiation","volume":"62","author":"K Ariyoshi","year":"2021","journal-title":"J Radiat Res (Tokyo)"},{"issue":"06","key":"ref90","doi-asserted-by":"crossref","first-page":"5703","DOI":"10.3390\/ijms24065703","article-title":"Adipose mesenchymal stromal cell-derived exosomes carrying MiR-122-5p antagonize the inhibitory effect of dihydrotestosterone on hair follicles by targeting the TGF-\u03b21\/SMAD3 signaling pathway","volume":"24","author":"Y Liang","year":"2023","journal-title":"Int J Mol Sci"},{"key":"ref91","first-page":"7471246","article-title":"Exosomes secreted from adipose-derived stem cells are a potential treatment agent for immune-mediated alopecia","volume":"2022","author":"Y Li","year":"2022","journal-title":"J Immunol Res"},{"issue":"02","key":"ref92","first-page":"96","article-title":"Exosomes: a new effective non-surgical therapy for androgenetic alopecia?","volume":"18","author":"A K Gupta","year":"2020","journal-title":"Skinmed"},{"issue":"08","key":"ref93","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1111\/jocd.15008","article-title":"Exosome therapy in hair regeneration: a literature review of the evidence, challenges, and future opportunities","volume":"21","author":"Y Kost","year":"2022","journal-title":"J Cosmet Dermatol"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"815205","DOI":"10.3389\/fcell.2022.815205","article-title":"Potential of colostrum-derived exosomes for promoting hair regeneration through the transition from telogen to anagen phase","volume":"10","author":"H Kim","year":"2022","journal-title":"Front Cell Dev Biol"},{"issue":"09","key":"ref95","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1111\/jocd.15869","article-title":"Systematic review of exosome treatment in hair restoration: preliminary evidence, safety, and future directions","volume":"22","author":"A K Gupta","year":"2023","journal-title":"J Cosmet Dermatol"},{"issue":"11","key":"ref96","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1111\/jocd.15890","article-title":"Treatment of androgenetic alopecia by exosomes secreted from hair papilla cells and the intervention effect of LTF","volume":"22","author":"G Wang","year":"2023","journal-title":"J Cosmet Dermatol"},{"issue":"06","key":"ref97","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1001\/jamadermatol.2020.0465","article-title":"Efficacy and safety of topical clascoterone cream, 1%, for treatment in patients with facial acne: two phase 3 randomized clinical trials","volume":"156","author":"A Hebert","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"02","key":"ref98","first-page":"197","article-title":"Cortexolone 17\u03b1-propionate (clascoterone) is an androgen receptor antagonist in dermal papilla cells in vitro","volume":"18","author":"C Rosette","year":"2019","journal-title":"J Drugs Dermatol"},{"issue":"16","key":"ref99","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s40265-020-01417-6","article-title":"Clascoterone: first approval","volume":"80","author":"S Dhillon","year":"2020","journal-title":"Drugs"},{"issue":"07","key":"ref100","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/ced.14292","article-title":"Clascoterone as a novel treatment for androgenetic alopecia","volume":"45","author":"H Y Sun","year":"2020","journal-title":"Clin Exp Dermatol"},{"issue":"06","key":"ref101","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/cpdd.935","article-title":"A phase 1 study to investigate the effects of cortexolone 17\u03b1-propionate, also known as clascoterone, on the QT interval using the meal effect to demonstrate ECG assay sensitivity","volume":"10","author":"J T\u00e4ubel","year":"2021","journal-title":"Clin Pharmacol Drug Dev"},{"issue":"01","key":"ref102","doi-asserted-by":"crossref","first-page":"e13202","DOI":"10.1111\/dth.13202","article-title":"Topical ketoconazole for the treatment of androgenetic alopecia: a systematic review","volume":"33","author":"J R Fields","year":"2020","journal-title":"Dermatol Ther"},{"issue":"11","key":"ref103","doi-asserted-by":"crossref","first-page":"5519","DOI":"10.1111\/jocd.15309","article-title":"Topical cetirizine for treating androgenetic alopecia: A systematic review","volume":"21","author":"X Chen","year":"2022","journal-title":"J Cosmet Derma tol"},{"issue":"01","key":"ref104","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/jdv.14624","article-title":"Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men -short version","volume":"32","author":"V Kanti","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref105","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/1346-8138.14470","article-title":"Drafting Committee for the Guidelines for the Diagnosis and Treatment of Male-and Female-Pattern Hair Loss. Guidelines for the diagnosis and treatment ofmale-pattern and female-pattern hair loss, 2017 version","volume":"45","author":"M Manabe","year":"2018","journal-title":"J Dermatol"},{"key":"ref106","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.2147\/DDDT.S214907","article-title":"Minoxidil and its use in hair disorders: a review","volume":"13","author":"P Suchonwanit","year":"2019","journal-title":"Drug Des, Develop Ther"},{"issue":"06","key":"ref107","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.jaad.2021.02.054","article-title":"Safety of low-dose oral minoxidil for hair loss: a multicenter study of 1404 patients","volume":"84","author":"S Va\u00f1\u00f3-Galv\u00e1n","year":"2021","journal-title":"J Amer Acad Dermatol"}],"container-title":["Facial Plastic Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2196-4713.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T16:21:02Z","timestamp":1730823662000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2196-4713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,23]]},"references-count":106,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2024,3,18]]},"published-print":{"date-parts":[[2024,4]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2196-4713","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0736-6825","1098-8793"],"issn-type":[{"value":"0736-6825","type":"print"},{"value":"1098-8793","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,10,23]]},"published":{"date-parts":[[2023,10,23]]}}}